{{Rsnum
|rsid=17065417
|Gene=LIN28B
|Chromosome=6
|position=104958399
|Orientation=plus
|GMAF=0.06428
|Gene_s=LIN28B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 85.8 | 14.2 | 0.0
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 76.2 | 22.4 | 1.4
| ASW | 80.7 | 17.5 | 1.8
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 78.2 | 20.8 | 1.0
| LWK | 86.4 | 12.7 | 0.9
| MEX | 87.9 | 12.1 | 0.0
| MKK | 64.5 | 31.6 | 3.9
| TSI | 82.4 | 15.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22941191
  |Trait=Neuroblastoma
  |Title=Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
  |RiskAllele=A
  |Pval=1E-8
  |OR=1.38
  |ORtxt=[1.23-1.54]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}